Product Information

TACROLIMUS 0.1% OINTMENT is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $1.0665 per GM under NDC 45802070001. Its NADAC has been published 613 times since Feb 18, 2015.

FDA first approved this application on Dec 8, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TACROLIMUS 0.1% OINTMENT

Tacrolimus
$1.0665per GM

Strength

1 mg/g

NDC

45802070001

Classification

Generic

Dosage Form

OINTMENT

Route

TOPICAL

Effective Date

10/21/2026

Active Ingredients

TACROLIMUS

Approval Type

New Drug (NDA)

FDA Application

NDA050777

FDA Approved

12/8/2000

TE Code

AB

On Market Since

11/20/2014

Pharmacological Classes

Price Statistics

The NADAC for TACROLIMUS 0.1% OINTMENT has been published 613 times since Feb 18, 2015, and over the history we have for it it has declined 83.3%. The table below summarizes its recorded NADAC range and movement.

Current price$1.0665 per GM
All-time high$6.3818 (Apr 15, 2015)
All-time low$0.7211 (Jan 22, 2025)
52-week high$1.0665
52-week low$0.8748
Median price$2.4543
Average price$3.1069
Largest weekly change+63.0% (Nov 22, 2023)
Weeks tracked613
Tracking sinceFeb 18, 2015

Price History

1W

0.0%

1M

+13.1%

3M

+18.7%

6M

+20.9%

1Y

+13.5%

3Y

-12.0%

5Y

-49.9%

All

-83.3%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TACROLIMUS 0.1% OINTMENT?

The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 0.1% OINTMENT, manufactured by Padagis Israel Pharmaceuticals Ltd, is $1.0665 per GM (NDC 45802070001), effective Nov 11, 2026.

How has the price of TACROLIMUS 0.1% OINTMENT changed over time?

Over the history we have for it, the NADAC for TACROLIMUS 0.1% OINTMENT has declined 83.3%. It has been tracked across 613 weekly CMS publications since Feb 18, 2015.

What are the highest and lowest recorded NADAC prices for TACROLIMUS 0.1% OINTMENT?

Since Feb 18, 2015, the NADAC for TACROLIMUS 0.1% OINTMENT has ranged from a low of $0.7211 (Jan 22, 2025) to a high of $6.3818 (Apr 15, 2015), with a median of $2.4543 per GM.

Are there cheaper alternatives to TACROLIMUS 0.1% OINTMENT?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TACROLIMUS 0.1% OINTMENT, is $0.8823 per GM — about 17% below TACROLIMUS 0.1% OINTMENT.

Who manufactures TACROLIMUS 0.1% OINTMENT?

TACROLIMUS 0.1% OINTMENT (NDC 45802070001) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.